News

President Donald Trump added a new wrinkle to ongoing talks that he says may help end the war in Ukraine: new "economic development" with Russia.

Infrastructure construction company Primoris (NYSE:PRIM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 14.9% year on year to $1.74 billion. Its non-GAAP profit of $1.13 per share was 51.2% above analysts’ consensus estimates.

The operator of the OKX cryptocurrency exchange pleaded guilty on Monday to violating U.S. anti-money laundering laws and will pay nearly $505 million in fines and forfeited fees, the U.S. Department of Justice said. It entered its plea at a hearing before U.S. District Judge Katherine Polk Failla in Manhattan, who imposed the sentence. OKX is the world's fourth-ranked cryptocurrency spot exchange based on traffic, liquidity, trading volumes, and confidence in the legitimacy of reported trading volumes, according to CoinMarketCap.

Stocks are eyeing a rebound as investors eye tariff risks to Nvidia in the countdown to its earnings

Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 7.1% year on year to $210.6 million. The company’s full-year revenue guidance of $850 million at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.

3D measurement and imaging company FARO (NASDAQ:FARO) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 5.4% year on year to $93.54 million. The company expects next quarter’s revenue to be around $81 million, close to analysts’ estimates. Its non-GAAP profit of $0.50 per share was 25% above analysts’ consensus estimates.

Video conferencing platform Zoom (NASDAQ:ZM) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 3.3% year on year to $1.18 billion. On the other hand, next quarter’s revenue guidance of $1.16 billion was less impressive, coming in 0.8% below analysts’ estimates. Its non-GAAP profit of $1.41 per share was 4.6% above analysts’ consensus estimates.